GO:0050765 negative regulation of phagocytosis: Immune Checkpoint Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050765 negative regulation of phagocytosis describes any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis, the cellular engulfment of particles or cells.
• The Src family kinase Fgr was among the first molecules shown to negatively regulate phagocytosis in murine macrophages, establishing a paradigm for inhibitory signaling in innate immunity.
• Genome-wide genetic screens have identified CYRI-B as a negative regulator of CEACAM3-mediated phagocytosis, demonstrating that dedicated inhibitory pathways can be systematically discovered.
• Tumor cells exploit negative regulation of phagocytosis through CD47-SIRPα and CD43 sialylation to evade macrophage clearance, making this process a major immuno-oncology target.
• Efferocytosis, the phagocytic clearance of apoptotic cells, is subject to negative regulation by Arid3a and the TRIM28/miR133a/CD47 axis, linking GO:0050765 to cholestasis and pancreatic necrosis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which candidate genes causally restrain phagocytosis in health and disease.
Description
Phagocytosis is a fundamental innate immune process by which cells engulf and degrade particles, microbes, and apoptotic cells. However, unrestrained phagocytosis can cause tissue damage and autoimmunity, so organisms have evolved dedicated negative regulatory mechanisms. GO:0050765 negative regulation of phagocytosis is the Gene Ontology term that captures any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis. This term is critical for understanding how immune responses are balanced and how pathogens and tumors subvert clearance mechanisms.
negative regulation of phagocytosis At A Glance
| GO ID | GO:0050765 |
|---|---|
| GO term | negative regulation of phagocytosis |
| Ontology | biological_process |
| Definition | Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis. |
| Synonyms | down regulation of phagocytosis; down-regulation of phagocytosis; downregulation of phagocytosis; inhibition of phagocytosis |
| Major function | Suppression of phagocytic uptake and clearance, controlling immune homeostasis and preventing excessive inflammation |
| Related processes | Efferocytosis, CEACAM3-mediated phagocytosis, Fc receptor signaling, immune checkpoint regulation |
| Key negative regulators | Fgr, CYRI-B, CD47, CD43, Arid3a, TRIM28/miR133a axis |
| Disease relevance | Cancer immune evasion, cholestasis, pancreatic necrosis, and impaired clearance in inflammatory disease |
What Is GO:0050765?
GO:0050765 negative regulation of phagocytosis is defined as any biological process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis. In practice, this includes inhibitory signaling pathways, checkpoint molecules, and genetic programs that suppress the engulfment of targets by phagocytes such as macrophages, neutrophils, and dendritic cells. The term is a biological_process child of negative regulation of cellular process and is distinct from positive regulation of phagocytosis.
Why Is negative regulation of phagocytosis Important in Cell Biology?
Negative regulation of phagocytosis is essential for preventing tissue damage from excessive engulfment and for maintaining immune tolerance. Dysregulation of this process contributes to cancer immune evasion, where tumor cells upregulate anti-phagocytic signals such as CD47 and sialylated CD43 to avoid macrophage clearance. Conversely, impaired negative regulation can lead to pathological efferocytosis in cholestasis and pancreatic necrosis. Understanding GO:0050765 therefore has direct therapeutic implications for immuno-oncology and inflammatory diseases.
• Controls the balance between pathogen clearance and tissue damage in innate immunity.
• Enables tumor cells to evade macrophage phagocytosis via CD47-SIRPα and CD43 sialylation.
• Regulates efferocytosis of apoptotic cells, preventing secondary necrosis and inflammation.
• Provides targets for cancer immunotherapy, such as blocking Vtn-C1qbp interaction to enhance phagocytosis.
• Influences outcomes in triple-negative breast cancer through efferocytosis-related signatures.
• Is amenable to genome-wide CRISPR screening for discovery of novel negative regulators like CYRI-B.
• Links hormonal and metabolic signals to phagocytic capacity in unicellular and multicellular organisms.
• Guides development of anti-inflammatory therapies for cholestasis and pancreatic necrosis.
What Happens During negative regulation of phagocytosis?
Initiation of inhibitory signaling
In simple terms: A 'don't eat me' signal is received by the phagocyte.
Negative regulation begins when phagocytes encounter inhibitory ligands on target cells or in their environment. For example, sialylated CD43 on leukemia cells forms a glyco-immune barrier that restrains antileukemic immunity by engaging inhibitory receptors. Similarly, CD47 on tumor cells interacts with SIRPα on macrophages to deliver an inhibitory signal. These interactions recruit phosphatases such as SHP-1 that counteract activating signals.
Suppression of phagocytic receptor activation
In simple terms: The machinery that would normally engulf the target is switched off.
Inhibitory signaling blocks the activation of phagocytic receptors such as Fcγ receptors and CEACAM3. The Src family kinase Fgr was shown to negatively regulate phagocytosis in murine macrophages, likely by interfering with activating kinase cascades. Genome-wide screens identified CYRI-B as a negative regulator of CEACAM3-mediated phagocytosis, acting downstream of receptor engagement. This step prevents actin remodeling and particle internalization.
Regulation of efferocytosis
In simple terms: The clearance of dead cells is kept in check.
Efferocytosis, the phagocytosis of apoptotic cells, is subject to negative regulation to avoid excessive clearance. Arid3a impairs Mertk-mediated efferocytosis in cholestasis, demonstrating transcriptional control of this process. The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis. These examples show that negative regulation of phagocytosis is tissue-specific and disease-relevant.
Hormonal and metabolic modulation
In simple terms: Body signals can dial phagocytosis up or down.
Phagocytosis is subject to hormonal regulation at both unicellular and multicellular levels, as reviewed by Csaba. This implies that endocrine signals can negatively regulate phagocytic activity, integrating immune function with systemic physiology. Such modulation may explain why metabolic disorders affect susceptibility to infections and clearance of debris.
Outcomes: immune evasion and tissue protection
In simple terms: The result is either protection from damage or unwanted immune escape.
When negative regulation is beneficial, it prevents tissue damage from excessive phagocytosis. When hijacked by tumors, it leads to immune evasion. Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis. Efferocytosis-related signatures predict outcomes and immunotherapy response in triple-negative breast cancer. Thus, the balance of negative regulation determines disease outcome.
Key Genes Involved in GO:0050765 negative regulation of phagocytosis
The following genes and proteins have been experimentally implicated in negative regulation of phagocytosis (GO:0050765) or in related phagocytic control pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Fgr | Src family kinase that negatively regulates phagocytosis in murine macrophages | First established negative regulator; model for inhibitory signaling |
| CYRI-B | Negative regulator of CEACAM3-mediated phagocytosis | Identified by genome-wide screen; controls bacterial uptake |
| CD47 | Provides 'don't eat me' signal via SIRPα | Target for cancer immunotherapy; regulated by TRIM28/miR133a axis |
| CD43 | Sialylated glyco-immune barrier restraining antileukemic immunity | Antibody blockade enhances phagocytosis in leukemia |
| Arid3a | Transcription factor impairing Mertk-mediated efferocytosis | Linked to cholestasis; regulates apoptotic cell clearance |
| TRIM28 | E3 ligase regulating miR133a and CD47 expression | Therapeutic target in pancreatic necrosis |
| Mertk | Receptor tyrosine kinase mediating efferocytosis | Negatively regulated by Arid3a in cholestasis |
| SIRPα | Inhibitory receptor on macrophages binding CD47 | Checkpoint target to enhance phagocytosis |
| Vtn | Vitronectin interacting with C1qbp | Blocking Vtn-C1qbp enhances macrophage phagocytosis and inhibits tumor progression |
| C1qbp | Complement component 1 Q subcomponent binding protein | Partner of Vtn in tumor-macrophage communication |
| CEACAM3 | Phagocytic receptor for Neisseria | Negatively regulated by CYRI-B |
| miR133a | MicroRNA downstream of TRIM28 | Modulates CD47 and efferocytosis |
| SHP-1 | Phosphatase recruited by inhibitory receptors | Counteracts activating signals in phagocytosis |
| FcγR | Activating phagocytic receptor | Subject to negative regulation by Fgr and others |
| Rac1 | Rho GTPase involved in actin remodeling | Target of inhibitory signals |
| Cdc42 | Rho GTPase involved in phagocytic cup formation | Potential downstream effector of negative regulation |
| MerTK | Receptor for efferocytosis | Negatively regulated by Arid3a |
| Gas6 | Ligand for MerTK | Modulates efferocytosis efficiency |
How Is negative regulation of phagocytosis Regulated?
Negative regulation of phagocytosis is itself regulated at multiple levels. Transcriptionally, Arid3a represses Mertk expression to impair efferocytosis in cholestasis. Post-transcriptionally, the TRIM28/miR133a axis controls CD47 levels, thereby influencing phagocytic clearance in pancreatic necrosis. Hormonal signals can also modulate phagocytic capacity, as reviewed by Csaba. Additionally, genome-wide screens have revealed that CYRI-B acts as a negative regulator downstream of CEACAM3, suggesting post-translational control. These layers of regulation ensure context-dependent suppression of phagocytosis.
negative regulation of phagocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD47 | Cancer immune evasion; pancreatic necrosis | CD47 knockout or overexpression in tumor cells; syngeneic mouse models |
| CD43 | Leukemia immune evasion | Sialylation-deficient knock-in or knockout in leukemia cell lines |
| Arid3a | Cholestasis; impaired efferocytosis | Liver-specific Arid3a knockout or overexpression in mice |
| CYRI-B | Bacterial infection; CEACAM3-mediated phagocytosis | CYRI-B knockout macrophages; Neisseria infection assays |
| Vtn/C1qbp | Tumor progression; macrophage phagocytosis | Blocking antibodies or knockout in tumor-macrophage co-cultures |
Cancer immune evasion
Tumor cells exploit negative regulation of phagocytosis to avoid macrophage clearance. Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity, and targeting this barrier enhances phagocytosis. CD47 upregulation, controlled by the TRIM28/miR133a axis, provides a 'don't eat me' signal in pancreatic necrosis and other cancers. Blocking Vtn-C1qbp interaction inhibits tumor progression by enhancing macrophage phagocytosis. Efferocytosis-related signatures predict outcomes and immunotherapy response in triple-negative breast cancer.
Cholestasis and liver disease
Arid3a impairs Mertk-mediated efferocytosis in cholestasis, leading to accumulation of apoptotic cells and liver injury. This demonstrates that negative regulation of phagocytosis can be maladaptive in the liver, contributing to disease pathogenesis. Modulating this pathway may offer therapeutic benefit.
Pancreatic necrosis
The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis. Negative regulation of phagocytosis in this context prevents clearance of necrotic debris, exacerbating inflammation. Targeting this axis could restore efferocytosis and limit tissue damage.
Infectious disease and hormonal regulation
Negative regulation of phagocytosis also impacts host-pathogen interactions. CYRI-B negatively regulates CEACAM3-mediated phagocytosis of Neisseria, potentially affecting bacterial clearance. Hormonal signals can modulate phagocytosis at unicellular and multicellular levels, linking endocrine status to infection susceptibility.
From negative regulation of phagocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate phagocytosis? | CRISPR knockout in macrophage cell line (e.g., RAW264.7, THP-1) followed by phagocytosis assay |
| Does a specific point mutation in gene X alter its inhibitory function? | CRISPR point mutation knock-in in primary macrophages or iPSC-derived macrophages |
| Does overexpression of gene X suppress phagocytosis? | Lentiviral overexpression in macrophages or tumor cells |
| Does tagging gene X reveal its localization during phagocytosis? | CRISPR knock-in of fluorescent tag (e.g., GFP) |
| Which genes negatively regulate phagocytosis genome-wide? | CRISPR library screening in phagocytic cells |
| Does hormonal signaling modulate negative regulation of phagocytosis? | In vitro phagocytosis assays with hormone treatment in unicellular and multicellular models |
How to Study the negative regulation of phagocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent bead phagocytosis assay | Rate and extent of particle uptake | Testing negative regulators in macrophages |
| CRISPR knockout screen | Genes whose loss enhances phagocytosis | Discovery of negative regulators like CYRI-B |
| Single-cell RNA-seq | Transcriptional signatures of efferocytosis | Predicting outcomes in TNBC |
| Flow cytometry | Percentage of phagocytosing cells | Quantifying phagocytosis in mixed populations |
| Live-cell imaging | Dynamics of phagocytic cup formation | Visualizing inhibition by Fgr or CD47 |
| Immunoblotting | Phosphorylation of signaling proteins | Assessing inhibitory signaling pathways |
| ELISA | Cytokine release after phagocytosis | Linking negative regulation to inflammation |
| Co-culture assays | Tumor cell-macrophage interaction | Testing Vtn-C1qbp blockade |
Phagocytosis assays
Quantitative phagocytosis assays using fluorescent beads, bacteria, or apoptotic cells are the gold standard to measure the rate and extent of engulfment. These assays can be combined with genetic perturbations to test negative regulators.
CRISPR screening
Genome-wide CRISPR knockout or activation screens enable unbiased discovery of negative regulators of phagocytosis. Kuiper et al. used such a screen to identify CYRI-B as a negative regulator of CEACAM3-mediated phagocytosis.
Single-cell analysis and machine learning
Single-cell RNA sequencing combined with machine learning can identify efferocytosis-related signatures and predict outcomes in cancer, as shown in triple-negative breast cancer. This approach helps link negative regulation of phagocytosis to clinical phenotypes.
Flow cytometry and imaging
Flow cytometry quantifies phagocytic uptake at single-cell resolution, while live-cell imaging reveals the dynamics of phagocytic cup formation and inhibition. These methods are essential to validate findings from genetic screens.
How CRISPR Can Be Used to Study GO:0050765 negative regulation of phagocytosis
Knockout
CRISPR knockout of candidate negative regulators such as Fgr, CYRI-B, or CD47 can be used to test whether their loss enhances phagocytosis. For example, Fgr knockout macrophages show increased phagocytic activity. CYRI-B knockout enhances CEACAM3-mediated phagocytosis.
Point Mutation
Point mutations can dissect specific domains or phosphorylation sites required for negative regulation. For instance, mutating the kinase domain of Fgr or the inhibitory ITIM motifs in SIRPα can reveal their functional importance.
Knock-in
Knock-in of fluorescent tags or reporter genes allows tracking of negative regulators in live cells. Tagging CYRI-B or CD47 with GFP can reveal their localization during phagocytosis.
Overexpression
Overexpression of negative regulators such as CD47 or sialylated CD43 can suppress phagocytosis and promote immune evasion. This approach is useful to model tumor immune evasion and test therapeutic antibodies.
How EDITGENE Supports negative regulation of phagocytosis Research
Researchers studying negative regulation of phagocytosis-related genes often need to determine whether a candidate gene is causally involved in suppressing phagocytic uptake. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of phagocytosis research.
Frequently Asked Questions About negative regulation of phagocytosis
What is negative regulation of phagocytosis (GO:0050765)?
It is any biological process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis, the cellular engulfment of particles or cells.
What genes are involved in negative regulation of phagocytosis?
Key genes include Fgr, CYRI-B, CD47, CD43, Arid3a, TRIM28, and Mertk, among others.
How does CD47 inhibit phagocytosis?
CD47 on target cells binds SIRPα on macrophages, delivering an inhibitory signal that prevents engulfment.
What is the role of Fgr in phagocytosis?
Fgr is a Src family kinase that negatively regulates phagocytosis in murine macrophages.
How is negative regulation of phagocytosis studied?
It is studied using phagocytosis assays, CRISPR screens, single-cell RNA-seq, flow cytometry, and imaging.
Why is negative regulation of phagocytosis important in cancer?
Tumors exploit it to evade macrophage clearance, making it a target for immunotherapy.
What is CYRI-B and how does it relate to phagocytosis?
CYRI-B is a negative regulator of CEACAM3-mediated phagocytosis identified by genome-wide screen.
Can negative regulation of phagocytosis be targeted therapeutically?
Yes, blocking CD47-SIRPα or Vtn-C1qbp interactions enhances phagocytosis and inhibits tumor progression.
What diseases are linked to defective negative regulation of phagocytosis?
Cholestasis, pancreatic necrosis, and cancer immune evasion are linked to dysregulated negative regulation.
How can CRISPR help study negative regulation of phagocytosis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes.
Conclusion
GO:0050765 negative regulation of phagocytosis is a critical biological process that balances immune clearance and tissue protection. Its dysregulation contributes to cancer immune evasion, cholestasis, and pancreatic necrosis. Understanding the molecular players such as Fgr, CYRI-B, CD47, and Arid3a provides opportunities for therapeutic intervention. CRISPR-based models are indispensable for dissecting these pathways and developing new treatments.
References
- 1. Chung J et al.. 2026. Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.. Science 392(6794):eady5196 PMID: 41955354
- 2. Zhang C et al.. 2024. Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis.. Theranostics 14(7):2757-2776 PMID: 38773982
- 3. Zhu Q et al.. 2024. The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis.. Mol Ther 32(9):3025-3041 PMID: 38872307
- 4. Csaba G. 2017. Is there a hormonal regulation of phagocytosis at unicellular and multicellular levels? A critical review.. Acta Microbiol Immunol Hung 64(4):357-372 PMID: 28859501
- 5. Chen R et al.. 2023. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.. J Hepatol 79(6):1478-1490 PMID: 37659731
- 6. Wei L et al.. 2025. Efferocytosis-related signatures identified via Single-cell analysis and machine learning predict TNBC outcomes and immunotherapy response.. Sci Rep 15(1):38955 PMID: 41198835
- 7. Gresham HD et al.. 2000. Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr.. J Exp Med 191(3):515-28 PMID: 10662797
- 8. Kuiper JWP et al.. 2023. A genome-wide genetic screen identifies CYRI-B as a negative regulator of CEACAM3-mediated phagocytosis.. J Cell Sci 136(11) PMID: 37264948
